BCM
CVS icon

Bayesian Capital Management’s CVS Health CVS Stock Holding History

Bayesian Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$201K Sell
2,801
-4,447
-61% -$343K 0.25% 118
2025
Q4 		$575K Sell
7,248
-10,552
-59% -$832K 1.32% 21
2025
Q3 		$1.34M Sell
17,800
-49,700
-74% -$3.41M 0.27% 112
2025
Q2 		$4.66M Sell
67,500
-12,200
-15% -$800K 0.74% 20
2025
Q1 		$5.4M Buy
+79,700
New +$4.77M 0.89% 15
2024
Q4 		– Sell
-61,100
Closed -$3.84M – 744
2024
Q3 		$3.84M Buy
+61,100
New +$3.56M 0.45% 44
2024
Q1 		– Sell
-171,400
Closed -$13.5M – 837
2023
Q4 		$13.5M Sell
171,400
-48,100
-22% -$3.42M 1.44% 6
2023
Q3 		$15.3M Buy
219,500
+172,700
+369% +$12.2M 1.75% 3
2023
Q2 		$3.24M Sell
46,800
-13,279
-22% -$945K 0.35% 53
2023
Q1 		$4.46M Buy
60,079
+24,900
+71% +$2.09M 0.55% 28
2022
Q4 		$3.28M Buy
+35,179
New +$3.39M 0.48% 23
2022
Q1 		– Sell
-3,200
Closed -$330K – 798
2021
Q4 		$330K Buy
+3,200
New +$296K 0.1% 243
2021
Q2 		– Sell
-5,466
Closed -$411K – 456
2021
Q1 		$411K Buy
+5,466
New +$398K 0.09% 270
2020
Q4 		– Sell
-56,300
Closed -$3.29M – 492
2020
Q3 		$3.29M Buy
56,300
+49,200
+693% +$3.06M 0.8% 15
2020
Q2 		$461K Sell
7,100
-16,600
-70% -$1.05M 0.1% 253
2020
Q1 		$1.41M Sell
23,700
-24,400
-51% -$1.63M 0.3% 72
2019
Q4 		$3.57M Sell
48,100
-21,600
-31% -$1.52M 0.61% 23
2019
Q3 		$4.4M Buy
+69,700
New +$4.13M 0.83% 18
2019
Q1 		– Sell
-27,202
Closed -$1.78M – 591
2018
Q4 		$1.78M Buy
27,202
+21,471
+375% +$1.6M 0.36% 55
2018
Q3 		$451K Buy
+5,731
New +$410K 0.07% 355
2016
Q4 		– Sell
-11,067
Closed -$985K – 614
2016
Q3 		$985K Buy
11,067
+4,529
+69% +$428K 0.65% 22
2016
Q2 		$626K Buy
+6,538
New +$652K 0.37% 83

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bayesian Capital Management's CVS Position: Q1 2026 in Review

Bayesian Capital Management reduced its CVS Health (CVS) stake by 61% in Q1 2026, selling an estimated $343K and leaving 2,801 shares worth $201K. The position accounts for 0.25% of the portfolio, ranked #118.

Bayesian Capital Management first reported a position in CVS in Q2 2016 and has held it in 22 quarters since. The position peaked at $15.3M in Q3 2023. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Bayesian Capital Management held 2,801 shares of CVS Health worth $201K as of Q1 2026.
  • Bayesian Capital Management sold 4,447 CVS Health shares in Q1 2026, an estimated $343K.
  • CVS Health made up 0.25% of Bayesian Capital Management's portfolio in Q1 2026, its #118 holding.
  • Bayesian Capital Management first reported a position in CVS Health in Q2 2016 and has held it in 22 quarters since.
  • Bayesian Capital Management's CVS Health position peaked at $15.3M in Q3 2023.
  • 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Bayesian Capital Management's 13F filing for Q1 2026, filed 15 May 2026.